Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety

Alex Therapeutics Sweden

Almee™, developed by Alex Therapeutics in partnership with Vicore Pharma, is a mobile app that offers personalized treatment for anxiety based on cognitive behavioral therapy (CBT)The pivotal trial demonstrated significantly reduced levels of anxiety and improved quality of life for people living with pulmonary fibrosis, a chronic and fatal diseaseView original content:https://www.prnewswire.co.uk/news-releases/alex-therapeutics-reports-positive-results-from-the-randomized-controlled-trial-of-its-digital-therapy-for-anxiety-302026100.html